Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851-01.
Published August 20, 2025 · Recall initiated: July 29, 2025
Summary
FDA records drug Class II recall D-0575-2025, published August 20, 2025 and initiated July 29, 2025. Recalling firm: Pfizer; Status: Ongoing; Reported quantity: 29, 004 bottles; Lot: Lot #: 24C11, Exp 2/28/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent drug
What to do
Voluntary: Firm initiated · Letter
Get an email if LEVOXYL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LEVOXYL
- Manufacturer
- Pfizer
- Distributor
- Within U.S
- UPC
- 0360793856018
- Lot
- Lot #: 24C11, Exp 2/28/2026.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALevoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 100 tablet bottle, Rx only, Distributed byOctober 28, 2026
- FDALevoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 1000-count bottle, Rx only, Distributed byOctober 28, 2026
- FDAAmlodipine and Olmesartan Medoxomil Tablets, 5 mg/ 40 mg, 30-count bottle, Rx Only, Manufactured by: AlkemAugust 20, 2025
- FDADxI 800 Access Immunoassay Analyzer W/Spot B, Part Number A71456August 13, 2025
- FDALEVOXYL Tablets, USD, 150MCG, 100-count bottle, Rx Only, Distributed by Pfizer Inc., New York, NY 10017, MADEJune 2, 2021
- FDALevoxyl (levothyroxine sodium tablets, USP) tablets 112 mcg, 100-count bottle, Rx Only,Distributed by PfizerDecember 26, 2018
Questions about this recall
Was Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851-01. recalled?
Yes. FDA published recall D-0575-2025 on August 20, 2025. Reported hazard: Subpotent drug
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LEVOXYL. UPC: 0360793856018.